From Wikidoc - Reading time: 2 min
|
WikiDoc Resources for Salicin |
|
Articles |
|---|
|
Most recent articles on Salicin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Salicin at Clinical Trials.gov Clinical Trials on Salicin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Salicin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Salicin Risk calculators and risk factors for Salicin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Salicin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Salicin (C13H18O7) is an alcoholic β-glycoside which contains D-glucose. Salicin is an anti-inflammatory which is produced from all willow barks. Salicin is closely related chemically to aspirin and has a very similar action in the human body. When consumed, it is metabolized to salicylic acid. The systematic (IUPAC) name of the molecule is 2-(Hydroxymethyl)phenyl β-D-glucopyranoside. It has the following classifications and chemical properties: